Last Updated:
2:19 pm
Wednesday, July 2, 2025
Atomo Diagnostics Ltd. engages in manufacture, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. It offers its products through the AtomoRapid range of RDT platforms. The company was founded by John Kelly in 2010 and is headquartered in Leichhardt, Australia.
asx-at1
Market Cap
AU$12.01M
Volume
255125
Open
0.01
AU$
High
0.01
AU$
Low
0.01
AU$
Shares On Issue
639M
52 Week Low
0.014
AU$
52 Week High
0.028
AU$
Website
www.atomodiagnostics.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved